newsmetry
rusign inget started
macro

UBS Keeps Neutral Ratings on Three U.S. Companies

UBS maintained Neutral ratings on Alignment Healthcare, Humana and Corteva. The bank cut ALHC’s target and raised HUM’s target price.

published
in the api
on the website

on the website stories appear 15 minutes after publication, in the api at once. connect the api →

Newsmetry newsroom

what happened

According to Newsmetry API, citing Benzinga, UBS maintained its Neutral rating on Alignment Healthcare (ALHC). The bank nevertheless cut its price target from $22.00 to $9.00 per share. The item was published at 21:21 GMT.

UBS also kept Humana (HUM) at Neutral while raising its price target from $405.00 to $495.00 per share. Newsmetry API and Benzinga reported this action at 21:19 GMT.

For Corteva (CTVA), UBS likewise maintained a Neutral rating. The report did not provide a new price target for the company and was published at 21:16 GMT.

why it matters

The actions update UBS’s view of three U.S. stocks spanning healthcare and agriculture. The target-price changes move in opposite directions for ALHC and HUM, while the Corteva item only confirms that its rating was retained.

instruments

ALHCHUMCTVA

sources

  1. Alignment Healthcare Is Maintained at Neutral by UBS — Newsmetry API, 12 October 2026 at 21:21 UTC
  2. Humana Is Maintained at Neutral by UBS — Newsmetry API, 12 October 2026 at 21:19 UTC
  3. Corteva Is Maintained at Neutral by UBS — Newsmetry API, 12 October 2026 at 21:16 UTC

prepared by the newsmetry newsroom with ai assistance from the sources listed below. not investment advice.

on the website stories appear 15 minutes after publication, in the api at once.

get stories in real time ↗

related stories